sibnayal
advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.
sibnayal 24 meq
elaiapharm - franta - combinatii (kalii citras+kalii hydrogen carbonas) - gran. elib. prel. - 24meq(847mg+1582mg) - potasium (kalium) medicamente cu potasiu
sibnayal 8 meq
elaiapharm - franta - combinatii (kalii citras+kalii hydrogen carbonas) - gran. elib. prel. - 8meq(282mg+527mg) - potasium (kalium) medicamente cu potasiu
piro-stop
ooo apicenna, federația rusă - imidocarb - soluţie injectabilă
ketojekt®
ooo apicenna, federația rusă - ketoprofen - soluţie injectabilă
ranosan®
ooo apicenna, federația rusă - cloramfenicol - pulbere
tepadina 100 mg
adienne s.r.l. s.u. - italia - thiotepum - pulb. pt. conc. pt. sol. perf. - 100mg - agenti alchilanti agenti alchilanti
tepadina 15 mg
adienne s.r.l. s.u. - italia - thiotepum - pulb. pt. conc. pt. sol. perf. - 15mg - agenti alchilanti agenti alchilanti
tepadina 400 mg
adienne s.r.l. s.u. - italia - thiotepum - pulb.+solv. pt. sol. perf. - 400mg - agenti alchilanti agenti alchilanti
phelinun
adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - agenți antineoplazici - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.